Scott Bizily 4 D Molecular Therapeutics, Inc. (FDMT) insider trading activity

Scott Bizily is Chief Legal Officer of 4D Molecular Therapeutics, Inc.. Currently has a direct ownership of 3,594 shares of FDMT, which is worth approximately $38,994. The most recent transaction as insider was on Nov 17, 2025, when has been sold 1,635 shares (Common Stock) at a price of $10.59 per share, resulting in proceeds of $17,314. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.59K

47.0% 3M change

47.0% 12M change

Total Value Held $38,994

Scott Bizily Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 17 2025	SELL Open market or private sale	$17,314 $10.59 p/Share	1,635 Reduced 31.27%	3,594 Common Stock
Nov 17 2025	BUY Exercise of conversion of derivative security	$6,768 $4.14 p/Share	1,635 Added 23.82%	5,229 Common Stock
Oct 24 2025	SELL Open market or private sale	$32,136 $12.0 p/Share	2,678 Reduced 42.7%	3,594 Common Stock
Oct 24 2025	BUY Exercise of conversion of derivative security	$7,035 $6.49 p/Share	1,084 Added 14.74%	6,272 Common Stock
Oct 16 2025	SELL Open market or private sale	$16,627 $10.17 p/Share	1,635 Reduced 23.96%	5,188 Common Stock
Oct 16 2025	BUY Exercise of conversion of derivative security	$6,768 $4.14 p/Share	1,635 Added 19.33%	6,823 Common Stock
Oct 09 2025	SELL Open market or private sale	$24,080 $10.0 p/Share	2,408 Reduced 31.7%	5,188 Common Stock

Sep 23 2025	SELL Open market or private sale	$19,256 $8.0 p/Share	2,407 Reduced 24.06%	7,596 Common Stock
Sep 16 2024	SELL Open market or private sale	$8,164 $16.33 p/Share	500 Reduced 6.87%	6,781 Common Stock
Sep 16 2024	BUY Exercise of conversion of derivative security	$3,245 $6.49 p/Share	500 Added 6.43%	7,281 Common Stock
Aug 19 2024	SELL Open market or private sale	$7,500 $15.0 p/Share	500 Reduced 6.87%	6,781 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	$3,245 $6.49 p/Share	500 Added 6.43%	7,281 Common Stock
Jul 16 2024	SELL Open market or private sale	$47,442 $27.11 p/Share	1,750 Reduced 20.51%	6,781 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 17.02%	8,531 Common Stock
Jul 11 2024	SELL Open market or private sale	$49,900 $25.0 p/Share	1,996 Reduced 22.74%	6,781 Common Stock
Jul 11 2024	BUY Exercise of conversion of derivative security	$31,496 $15.78 p/Share	1,996 Added 18.53%	8,777 Common Stock
Jul 01 2024	SELL Open market or private sale	$90,737 $21.36 p/Share	4,248 Reduced 70.98%	1,737 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$30,882 $7.27 p/Share	4,248 Added 41.51%	5,985 Common Stock
Jun 17 2024	SELL Open market or private sale	$41,492 $23.71 p/Share	1,750 Reduced 50.19%	1,737 Common Stock
Jun 17 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 33.42%	3,487 Common Stock
May 16 2024	SELL Open market or private sale	$44,712 $25.55 p/Share	1,750 Reduced 50.19%	1,737 Common Stock
May 16 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 33.42%	3,487 Common Stock
Apr 16 2024	SELL Open market or private sale	$45,045 $25.74 p/Share	1,750 Reduced 50.19%	1,737 Common Stock
Apr 16 2024	BUY Exercise of conversion of derivative security	$12,722 $7.27 p/Share	1,750 Added 33.42%	3,487 Common Stock
Apr 01 2024	SELL Open market or private sale	$259,102 $31.78 p/Share	8,153 Reduced 82.44%	1,737 Common Stock

Scott Bizily

Chief Legal Officer

Emeryville, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FDMT shares.

Notify only if

Value

Insider Trading

Get notified when an 4 D Molecular Therapeutics, Inc. insider buys or sells FDMT shares.

Notify only if

Operation

Value

Type

News

Receive news related to 4D Molecular Therapeutics, Inc.

Track Activities on FDMT

Account